It doesn’t sound real, but an Israeli startup is developing smartphone apps that it claims will engage specific neuro-immune processes in the brain to help drugs for cancer, or Parkinson’s, work better.

Say what? Think of it like the dopamine hit you get when you see a cute cat video, Remepy’s goal is to create custom-tailored apps that trigger the release of hormones and neurotransmitters in a patient’s brain to boost the effects of traditional drugs. 

The company calls it “digital molecules” and sees it as a huge leap forward in the evolution of medical treatments – a revolution on a par with inhalers and insulin pumps. 

It’s futuristic and fascinating. What do you think, is this really the future of medicine? Read on.